Onyvide from Merrimack Pharmaceuticals is the brand name for irinotecan, a medicine for metastatic pancreatic cancer. Onyvide utilises nanoliposomes to penetrate more effectively into the pancreas. The medication extends average life expectancy in this difficult-to-treat group of patients by two months.
